Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hyo-soo Kim, Ph.D
Seoul National University Hospital
Study Chair - Hyo-soo Kim, Ph.D
Seoul National University Hospital
Principal Investigator - Soo Lim, Ph.D
Seoul National University Bundang Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chonbuk National University Hospital
Cheonju, South Korea
Recruiting - Seoul National University Bundang Hospital
Seongnam-si, South Korea
Not, yet, recruiting - Seoul National Universityhospital
Seoul, South Korea
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jan 2021
- Primary completion
- 31 May 2021
- Completion
- 31 Jan 2022
- Last update posted
- 26 Apr 2021
- Registered enrollment
- 554
- Registry id
- NCT04858308
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.